UBS Group
CLOV icon

UBS Group’s Clover Health Investments CLOV Stock Holding History

UBS Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,600
Closed -$594K – 9588
2021
Q2 		$594K Buy
+44,600
New +$438K ﹤0.01% 4596

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group's CLOV Position: Q1 2026 in Review

UBS Group increased its Clover Health Investments (CLOV) stake by 34% in Q1 2026, buying an estimated $981K and bringing the position to 1,767,799 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #4560.

UBS Group first reported a position in CLOV in Q2 2020 and has held it in 24 quarters since. The position peaked at $6.98M in Q3 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • UBS Group held 1,767,799 shares of Clover Health Investments worth $3.11M as of Q1 2026.
  • UBS Group bought 452,475 Clover Health Investments shares in Q1 2026, an estimated $981K.
  • Clover Health Investments made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4560 holding.
  • UBS Group first reported a position in Clover Health Investments in Q2 2020 and has held it in 24 quarters since.
  • UBS Group's Clover Health Investments position peaked at $6.98M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.